Abstract
Purpose
In the last few years more robust evidence is emerging to point out at an increased rate of prematurity and low birth weight in singleton pregnancies following ART. Whether this increased rate is related to ART practice or to infertility per se, is still an open question. Our aim in this study was to explore this question by evaluating Protein C (ProC) Global assay in infertile women before ART treatment.
Methods
A cohort of 95 unselected and consecutive infertile women, eligible for ART, was prospectively recruited for the study. The control group included 77 matched healthy fertile women with a history of spontaneous conceptions. Pro C Global assay was evaluated in both groups. A full thrombophilic work-up was performed in the study group.
Results
ProC Global assay level was found to be significantly lower in the study as compared to the control group, corresponding to 0.78 ± 0.16 and 0.88 ± 0.16, respectively (P < 0.01). As well, abnormal ProC Global assay level of ≤ 0.8 was significantly higher in the study as compared to control group corresponding to 53 % and 29 %, respectively. ProC Global assay level was significantly lower in women within the study group found to have APCR, factor V Leiden and high factor VIII level, any thrombophilia or combined thrombophilia when compared to women without these thrombophilic risk factors.
Conclusions
Reduced ProC Global assay level is encountered in infertile women prior to ART treatment. This finding may suggest a unique anticoagulation Protein C pathway in infertile as compared to fertile women. Further studies are encouraged to explore this finding.
Similar content being viewed by others
References
Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Lippincot Williams & Wilkins; 2011. p. 1371–4.
Luke B, Keith LG. The contribution of singletons, twins, and triplets to low birth weight, infant mortality and handicap in the United States. J Reprod Med. 1992;37:661–6.
Blickstein I. Does assisted reproduction technology, per se, increase the risk of preterm birth? Br J Obstet Gynecol. 2006;113S:68–71.
Andersen N, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. Br Med J. 2000;320:1708–12.
Helmerhost FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. Br Med J. 2004;328:261–5.
Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol. 2004;103:551–63.
McDonald SD, Murphy K, Beyene J, Ohlsson A. Perinatal outcomes of singleton pregnancies achieved by in vitro fertilization: a systematic review and meta-analysis. Obstet Gynecol. 2005;27:449–59.
Romundstad LB, Romundstad PR, Sunde A, von Dduring V, Skjaerven R, GunVatten LJ. Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet. 2008;372:737–43.
Wisborg K, Ingerslev HJ, Henriksen TB. In vitro fertilization and preterm delivery, low birth weight, and admission to the neonatal intensive care unit: a prospective follow-up study. Fertil Steril. 2010;94:2012–6.
Henningsen AK, Pinborg A, Lidegaard Ø, Vestergaard C, Forman JL, Andersen AN. Perinatal outcome of singleton siblings born after assisted reproductive technology and spontaneous conception: Danish national sibling-cohort study. Fertil Steril. 2011;95:959–63.
Younis JS, Shukha M, Ben-Ami M, Izhaki I, Blumenfeld Z, Brenner B, et al. Evaluation of Protein C Global assay during normal pregnancy and after assisted reproduction. Obstet Gynecol. 2010;115:969–74.
Hron G, Kyrle PA, Kaider A, Philipp K, Pabinger I, Kollars M, et al. ProC Global and endogenous thrombin potential during pregnancy. Am J Obstet Gynecol. 2010;203:463–e1-6.
Robert A, Eschwege V, Hameg H, Drouet L, Aillaud MF. Anticoagulant response to Agkistrodon contortrix venom (ACV test): a new global test to screen for defects in the anticoagulant protein C Pathway. Thromb Haemost. 1996;75:562–6.
Dati F, Hafner G, Erbes H, Prellwitz W, Kraus M, Niemann F, et al. ProC Global: the first functional screening assay for the complete protein C pathway. Clin Chem. 1997;43:1719–23.
Tripodi A, Akhavan S, Asti D, Faioni EM, Mannucci PM. Laboratory screening of thrombophilia. Evaluation of the diagnostic efficacy of a global test to detect congenital deficiencies of the protein C anticoagulation pathway. Blood Coag Fibrinol. 1998;9:485–9.
Grand’Maison A, Bates SM, Johnston M, McRae S, Ginsberg JS. “ProC Global”: a functional screening test that predicts recurrent venous thromboembolism. Thromb Haemost. 2005;93:600–4.
Toulon P, Halbmeyer WM, Hafner G, Schmitt Y, Randgard B, Odpadlik M, et al. Screening for abnormalities of the Protein C anticoagulant pathway using the ProC Global assay. Results of European multicenter evaluation. Blood Coag Fibrinol. 2000;11:447–54.
De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood. 1996;87:3531–44.
Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: Part 1. Thromb Haemost. 1996;76:651–62.
Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344:1222–31.
Brenner B, Kupferminc MJ. Inherited thrombophilia and poor pregnancy outcome. Best Pract Res Clin Haematol. 2003;17:427–39.
Younis JS, Samueloff A. Gestational vascular complications. Best Pract Res Clin Haematol. 2003;16:135–51.
Younis JS, Radin O, Mirsky N, Izhaki I, Majara T, Bar-ami S, et al. First polar body and nucleolar precursor body morphology is related to the ovarian reserve of infertile women. Reprod BioMed Online. 2008;16:851–8.
Younis JS, Jadaon J, Izhaki I, Haddad S, Radin O, Bar-Ami S, et al. A Simple multivariate score could predict ovarian reserve, as well as pregnancy rate, in infertile women. Fertil Steril. 2010;94:655–61.
Sarig G, Aberbach I, Scliamser L, Blimenfeld Z, Brenner B. Evaluation of ProC Global assay in women with history of venous thromboembolism on hormonal therapy. Thromb Haemost. 2006;96:578–83.
Sarig G, Lanir N, Hoffman R, Brenner B. Protein C global assay in the evaluation of women with idiopathic pregnancy loss. Thromb Haemost. 2002;87:32–6.
Heilmann L, von Tempelhoff GF, Pollow K. Pro C Global assay in the evaluation of women with history of severe pre-eclampsia or HELLP syndrome. Clin Appl Throm Hemost. 2002;8:319–24.
Chan YY, Jayaprakasan K, Zamora J, Thornton JG, Raine-Fenning N, Coomarasamy A. The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review. Hum Reprod Update. 2011;17:761–71.
Penzias AS. Recurrent IVF, failure: other factors. Fertil Steril. 2012;97:1033–8.
Boomsma CM, Fauser BC, Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med. 2008;26:72–84.
Almog B, Levin I, Wagman I, Kapustiansky R, Lessing JB, Amit A, et al. Adverse obstetric outcome for the vanishing twin syndrome. Reprod Biomed Online. 2010;20:256–60.
Calhoun KC, Fritz MA, Steiner AZ. Examining the relationship between ovarian reserve, as measured by basal FSH levels, and the risk of poor obstetric outcome in singleton IVF gestations. Hum Reprod. 2011;26:3424–30.
Younis JS, Ben-Ami M, Izhaki I, Jadaon J, Brenner B, Sarig G. The association between poor ovarian response and thrombophilia in assisted reproduction. Eur J Obstet Gynecol Reprod Biol. 2013;166:65–9.
Imudia AN, Awonuga AO, Doyle JO, Kaimal AJ, Wright DL, Toth TL, et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril. 2012;97:1374–9.
Kalra SK, Ratcliffe SJ, Barnhart KT, Coutifaris C. Extended embryo culture and an increased risk of preterm delivery. Obstet Gynecol 2012;69–75.
Pinborg A, Loft A, Aaris Henningsen AK, Rasmussen S, Andersen AN. Infant outcome of 957 singletons born after frozen embryo replacement: the Danish National Cohort Study 1995–2006. Fertil Steril. 2010;94:1320–7.
Grandone E, Colaizzo D, Lo Bue A, Checola MG, Cittadini E, Margaglione M. Inherited thrombophilia and in vitro fertilization implantation failure. Fertil Steril. 2001;76:201–2.
Azem F, Many A, Ben Ami I, Yovel I, Amit A, Lessing JB, et al. Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod. 2004;19:368–70.
Qublan HS, Eid SS, Ababneh HA, Amarin ZO, Smadi AZ, Al-Khafaji FF, et al. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod. 2006;21:2694–6.
Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations are risk factors for implantation failure. Reprod Biomed Online. 2006;12:322–7.
Bellver J, Soares SR, Alvarez C, Muñoz E, Ramírez A, Rubio C, et al. The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Hum Reprod. 2008;23:278–84.
Vaquero E, Lazzarin N, Caserta D, Valensise H, Baldi M, Moscarini M, et al. Diagnostic evaluation of women experiencing repeated in vitro fertilization failure. Eur J Obstet Gynecol Reprod Biol. 2006;125:79–85.
Simur A, Ozdemir S, Acar H, Colakoğlu MC, Görkemli H, Balci O, et al. Repeated in vitro fertilization failure and its relation with thrombophilia. Gynecol Obstet Invest. 2009;67:109–12.
Rudick B, Su HI, Sammel MD, Kovalevsky G, Shaunik A, Barnhart K. Is factor V Leiden mutation a cause of in vitro fertilization failure? Fertil Steril. 2009;92:1256–9.
Di Nisio M, Rutjes AW, Ferrante N, Tiboni GM, Cuccurullo F, Porreca E. Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis. Blood. 2011;118:2670–8.
Acknowledgements
The authors thank Brenda Zecharia, Ruti Brill, Kochi Navone and Adina Katz for their assistance in blood samples collection, handling and freezing.
Author information
Authors and Affiliations
Corresponding author
Additional information
Capsule Protein C Global assay results are significantly lower in infertile patients, before ART treatment as compared to fertile healthy controls. This may support the notion that the increased perinatal risks in singleton pregnancies following ART treatment, is related to infertility per se and not to the technology.
Rights and permissions
About this article
Cite this article
Younis, J.S., Ben-Ami, M., Izhaki, I. et al. Reduced protein C Global assay level in infertile women prior to IVF-ET treatment. J Assist Reprod Genet 31, 101–107 (2014). https://doi.org/10.1007/s10815-013-0131-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-013-0131-x